Preterm birth and prom testing refers to the delivery of a baby before 37 weeks of pregnancy. Prom tests help detect preterm birth risks in pregnant women and enable taking preventive actions. They involve measuring the length of cervix and checking for preterm prelabor rupture of membranes. With increasing preterm birth rates worldwide, demand for prom tests has surged significantly. Prom tests allow for early diagnosis and treatment of preterm labors, thereby reducing health risks for both mother and child associated with preterm deliveries. The prom testing kits make the process convenient by allowing home use without visiting hospitals frequently during pregnancies. global preterm birth and prom testing market
The Global Preterm Birth And Prom Testing Market is estimated to be valued at US$ 1.95 Mn in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the Preterm Birth And Prom Testing market are Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG. These players are focused on developing innovative prom screening solutions and kits to capitalize on the high market demand.
The growing demand for easy-to-use, accurate and affordable prom screening and testing solutions is a major factor driving the market growth. With rising global preterm birth rates, there is increasing awareness about the benefits of early detection of preterm labor risks using prom tests. This is facilitating the adoption of prom testing worldwide.
The market players are actively expanding their global presence through new product launches, collaborations and partnerships. Various awareness campaigns about prom screening are further augmenting the market growth. The companies target emerging nations with large patient pools and increasing healthcare expenditures on maternal and childcare.
Market Drivers
The alarming rise in preterm birth incidence rates globally is a key factor propelling the demand for prom tests. As per WHO, prematurity is the leading cause of death in children under 5 years of age. Prom tests can significantly reduce preterm delivery risks and complications through early detection and timely interventions. Moreover, government initiatives promoting maternal and fetal healthcare are encouraging in many countries, thus driving the adoption of prom tests. Home-based testing with easy self-screening kits is further supporting the market growth by enhancing access and convenience.
Geopolitical situation on Preterm Birth And Prom Testing Market growth and strategies:
The current geopolitical turbulence and instability across several regions is negatively impacting the growth of the preterm birth and prom testing market. The ongoing conflicts and wars in countries like Ukraine, Yemen, Afghanistan etc is causing huge humanitarian crisis and mass displacement of populations. This is increasing the health risks for pregnant women in these conflict zones and preterm deliveries. The supply chain disruption and sanctions on some countries are also affecting the easy availability of essential testing kits and medical devices required. The market players need to devise strategies to ensure uninterrupted supply in difficult regions. They must work with international aid organizations to expand access to testing and treatment in remote areas affected by conflicts. New affordable point-of-care kits suitable for resource poor settings should be developed and distributed through partnerships. The governments and private bodies should increase funding for maternal healthcare facilities in unstable regions to handle preterm birth emergencies. Telemedicine can also be leveraged to provide consultations for high-risk pregnancies where on-ground movement is restricted. Adopting such measures can help mitigate the negative market impact of ongoing geopolitical issues.
Geographical region which accounts for highest value share in Preterm Birth And Prom Testing Market:
North America currently dominates the preterm birth and prom testing market and accounts for the largest share in terms of value. This is owing to factors like availability of advanced healthcare infrastructure, high awareness levels regarding screening tests, grown burden of preterm births, and presence of major market players in the region. The US particularly drives the regional market growth due to large patient pool, favorable reimbursement policies, and heavy investments in maternal health programs by both public and private organizations. The increasing focus on early diagnosis and prevention of preterm deliveries among expectant mothers through routine tests is further supporting market expansion. Moreover, approval and launches of novel testing kits by regional companies are also boosting revenue generation. Other developed markets of Europe and Asia Pacific are also showing high growth potential centered around nations like Germany, UK, Japan and China due to rising healthcare expenditures, efforts to reduce prematurity rates, and growing focus on women's health.
- Get more insights on